🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.
Salud Compra fuertePrecio actual
61,65 USD
Máx. histórico
2.925,00
12011 días
Split 1:10 del 17/11/2011
Caída desde máximo
-97,89%
Rango 52 semanas
37,06 – 95,49
Variación hoy
+3,56%
Cierre anterior
59,53
Rango de hoy
59,06 – 61,99
Volumen hoy
1.487.357
Peor caída histórica
-99,96%
16/12/1993 → 16/12/2016
Aún sin recuperar
Volatilidad anualizada ⓘ
231,86%
- Nombre completo
- Arrowhead Pharmaceuticals, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 711
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 107,71 USD (puede no estar actualizado)
- Primera cotización
- 16/12/1993
- Precio actualizado
- hace 9 horas
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.
| Fecha | Ratio |
|---|---|
| 17/11/2011 | 1:10 |
| 15/01/2004 | 1:65 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/05/2016 | 5,74 | 5,75 | 5,61 | 5,67 | -1,22% | 2,49% | 416.500 |
| 04/05/2016 | 5,74 | 5,87 | 5,66 | 5,74 | -1,20% | 3,66% | 479.100 |
| 03/05/2016 | 5,84 | 6,00 | 5,75 | 5,81 | -3,49% | 4,28% | 309.900 |
| 02/05/2016 | 5,78 | 6,03 | 5,64 | 6,02 | +3,97% | 6,75% | 479.900 |
| 29/04/2016 | 5,89 | 5,99 | 5,75 | 5,79 | -2,20% | 4,11% | 473.700 |
| 28/04/2016 | 5,94 | 6,14 | 5,83 | 5,92 | -0,34% | 5,22% | 480.100 |
| 27/04/2016 | 5,95 | 6,01 | 5,74 | 5,94 | -1,16% | 4,54% | 711.000 |
| 26/04/2016 | 6,22 | 6,24 | 5,86 | 6,01 | -3,69% | 6,11% | 842.800 |
| 25/04/2016 | 6,23 | 6,37 | 6,19 | 6,24 | -0,32% | 2,94% | 459.600 |
| 22/04/2016 | 6,12 | 6,34 | 6,06 | 6,26 | +2,12% | 4,58% | 395.300 |
| 21/04/2016 | 6,00 | 6,24 | 5,88 | 6,13 | -0,16% | 6,00% | 795.200 |
| 20/04/2016 | 6,29 | 6,30 | 6,04 | 6,14 | -1,76% | 4,12% | 818.600 |
| 19/04/2016 | 6,55 | 6,55 | 6,15 | 6,25 | -2,80% | 6,11% | 763.100 |
| 18/04/2016 | 6,18 | 6,50 | 6,15 | 6,43 | +3,21% | 5,66% | 987.700 |
| 15/04/2016 | 6,19 | 6,35 | 6,05 | 6,23 | +0,81% | 4,85% | 936.900 |
| 14/04/2016 | 5,89 | 6,20 | 5,75 | 6,18 | +4,04% | 7,64% | 1.164.100 |
| 13/04/2016 | 6,00 | 6,12 | 5,61 | 5,94 | +12,93% | 8,50% | 2.503.100 |
| 12/04/2016 | 5,20 | 5,28 | 5,05 | 5,26 | +1,94% | 4,48% | 337.100 |
| 11/04/2016 | 5,22 | 5,44 | 5,14 | 5,16 | -0,58% | 5,82% | 480.100 |
| 08/04/2016 | 5,48 | 5,48 | 5,01 | 5,19 | -2,81% | 8,58% | 831.200 |
| 07/04/2016 | 5,25 | 5,42 | 5,18 | 5,34 | +1,71% | 4,57% | 475.900 |
| 06/04/2016 | 5,15 | 5,30 | 5,08 | 5,25 | +2,94% | 4,27% | 482.600 |
| 05/04/2016 | 4,98 | 5,25 | 4,90 | 5,10 | +1,39% | 7,03% | 382.800 |
| 04/04/2016 | 4,90 | 5,30 | 4,90 | 5,03 | +2,65% | 8,16% | 977.500 |
| 01/04/2016 | 4,76 | 4,95 | 4,68 | 4,90 | +1,66% | 5,74% | 518.900 |
| 31/03/2016 | 4,72 | 4,91 | 4,70 | 4,82 | +1,69% | 4,45% | 392.100 |
| 30/03/2016 | 5,00 | 5,13 | 4,72 | 4,74 | -3,46% | 8,20% | 652.800 |
| 29/03/2016 | 4,43 | 4,99 | 4,26 | 4,91 | +9,84% | 16,48% | 688.900 |
| 28/03/2016 | 4,60 | 4,60 | 4,42 | 4,47 | -2,19% | 4,00% | 320.600 |
| 24/03/2016 | 4,25 | 4,68 | 4,25 | 4,57 | +3,86% | 10,12% | 354.500 |